Crouse Steven C. 4

What Happened
Steven C. Crouse, President — Diagnostic & Spatial Biology at Bio‑Techne, converted/exercised 600 restricted stock units (derivative exercise/conversion) on 2026-06-02. To satisfy tax withholding, 216 shares were surrendered/disposed at $49.77 per share, generating $10,750 in withholding. The filing also shows a related derivative disposition entry for 600 shares at $0, reflecting the conversion/exercise mechanics. Net shares delivered to Crouse from this transaction were 384 (600 acquired − 216 withheld).

Key Details

• Transaction date: 2026-06-02. Transaction codes: M = exercise/conversion of derivative; F = payment of exercise price or tax liability (withholding).
• Withholding: 216 shares withheld at $49.77/share = $10,750.
• Gross shares converted: 600 RSUs; net shares received: 384.
• Notable footnotes: F1 clarifies each restricted stock unit equals one common share; F3 indicates 600 RSUs vest on 6/2/2026 (the vesting that triggered this conversion); F17 notes a correction to a prior Form 4 that increases beneficial ownership by 40 shares.
• Shares owned after transaction: not specified in the provided excerpt of the filing.
• Filing timeliness: no late‑filing indicator provided in the excerpt.

Context
This was a routine conversion/vesting of restricted stock units with shares withheld to cover taxes (a common cashless-like withholding). M-code transactions are exercises/conversions of derivative awards; F-code transactions reflect tax withholding. Such withholding sales are administrative and do not necessarily indicate a buy or sell signal by the insider.